IFP Advisors
ATOS icon

IFP Advisors’s Atossa Therapeutics ATOS Stock Holding History

IFP Advisors’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$57 Buy
+29
New +$69 ﹤0.01% 5048

Other funds holding ATOS

RE
Rydar Equities Weatherford, Texas $194M AUM 23.21% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

IFP Advisors's ATOS Position: Q3 2026 in Review

IFP Advisors opened a new position in Atossa Therapeutics (ATOS) in Q3 2026: 29 shares worth $57. The stake represents ﹤0.01% of the portfolio and ranks #5048 among its holdings.

3 funds tracked by Wall St. Rank hold ATOS as of Q3 2026.

  • IFP Advisors held 29 shares of Atossa Therapeutics worth $57 as of Q3 2026.
  • Atossa Therapeutics was a new IFP Advisors position in Q3 2026.
  • Atossa Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5048 holding.
  • 3 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.